Catalent — Company Overview, News & Financial Data

Catalent (NYSE:CTLT) operates in the pharmaceutical industry, specializing in delivery technologies, development solutions, and manufacturing for drugs, biologics, gene therapies, and consumer health products. The company is known for its innovative approaches to solving some of the most pressing challenges in drug development and delivery, including enhancing bioavailability, optimizing drug delivery, and increasing the speed to market for new therapies. Catalent's projects range from early-stage development to full-scale production, and its objectives are focused on leveraging its expertise and technology platforms to accelerate the pace of innovation in healthcare, ensuring medicines are made more accessible and affordable to patients worldwide. Its operations span a global network, aiming to deliver high-quality solutions that improve patient outcomes and drive the future of medicine.